Breakthrough Treatment For Covid 19 In New Clinical Trial

Covid-19 Cases

The preliminary results of a clinical trial suggest a new treatment for covid-19

The new treatment dramatically reduces the number of patients needing intensive care, according to the uk company that developed it.

The treatment from southampton-based biotech synairgen uses a protein called interferon beta which the body produces when it gets a viral infection.

The protein is inhaled directly into the lungs of patients with coronavirus, using a nebuliser, in the hope that it will stimulate an immune response.

The initial findings suggest the treatment cut the odds of a covid-19 patient in hospital developing severe disease – such as requiring ventilation – by 79%.

Patients were two to three times more likely to recover to the point where everyday activities were not compromised by their illness, synairgen claims.

The double-blind trial involved 101 volunteers who had been admitted for treatment at nine uk hospitals for covid-19 infections.

Half of the participants were given the drug, the other half got what is known as a placebo – an inactive substance.

DOWNLOAD THE ROCKCITYFM APP AND LISTEN LIVE

Please subscribe to our newsletter

CONTACT US

Do you have any request or enquiry? Do not hesitate to send us an email and we'll get back to you, asap.

Sending

©2020 RockcityFM The Voice of the People

Need Help? Chat with us
or

Log in with your credentials

or    

Forgot your details?

or

Create Account